Genomic Applications Partnership Program (GAPP) │ Genome Canada

To be eligible for GAPP funding, projects must:

• develop and apply a genomics-derived or genomics-enabling solution (i.e., tool, product or process) to an opportunity or challenge clearly defined by the Receptor(s);
• focus on late stage R&D that will position the innovation for near term implementation/commercialization;
• be co-led by an Academic and a Receptor organization in partnership, with active and necessary roles for both (see Section 5 for GAPP project partner definitions); and,
• have the potential to generate significant social and/or economic benefits for Canadian stakeholders (see Section 6 for description of benefits to Canada).

Typically, a GAPP project involves either advancing a genomics technology that is emerging from Academic research or applying a solution (genomic or otherwise) derived from Academic research and expertise to add value to a Receptor product, tool or process. In the latter case, either the solution or the Receptor technology (but not necessarily both) must have a clear basis in genomics.